FBT250117C172000
- 0.00
- 0.000.00%
First Trust Exchange Traded Fund Nyse Arca Biotechnology Index Fund Newsroom
Wall Street Today: Market Turns Around, Let's See if it Lasts
Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge
Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
Live Stock News: Monday Market Falling, 'Too Big to Fail' Earnings to Start Q1 Report Season
Intra-Cellular Therapies Analyst Ratings
Intra-Cellular surged nearly 35%! Johnson & Johnson plans to spend $10 billion to acquire the company, marking the largest Biotechnology merger in nearly two years!
This is the largest Trade in the biotechnology Industry in nearly two years, and it is also the first Biomedical merger exceeding 10 billion dollars since 2024, indicating a resurgence in merger and acquisition activities in the Medical Care sector. Goldman Sachs stated that the potential financing capacity of large Biopharmaceutical companies is at least 500 billion dollars, providing significant operational space for R&D investment, merger expansion, and more.
Natera Shares Are Trading Higher After the Company Reported Preliminary FY24 Financial Results.
Today's Pre-Market Movers and Top Ratings | ANF, LULU, ITCI and More
12 Health Care Stocks Moving In Monday's Pre-Market Session
Immunology Company Argenx Estimates Higher Product Net Sales From Last Year
Johnson & Johnson Says Intra-Cellular Acquisition Includes CAPLYTA (Lumateperone), The First And Only US FDA-Approved Treatment For Bipolar I And II Depression As An Adjunctive And Monotherapy
Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
Biggest Stock Movers Monday: ITCI, and SAGE
Reported Earlier, Exelixis Reports $2.165B In Preliminary 2024 Revenue, Projects $2.15B-2.25B In 2025, And Highlights Pipeline Progress
Natera Guides Q4 and FY Revenue Above Consensus
Argenx Preliminary 2024 Financial Results: $2.2B In Annual Product Sales, $737M In Q4 Revenue, And $3.4B In Cash Reserves
Walgreens Boots Alliance, Aurora Innovation And Delta Air Lines Are Among Top Large Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?
Weekly Buzz: CES Came and Brought the Pain? That's Unexpected
Wall Street Today: Labor Gains Hurt a Hurting Market